Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...

Over the past six months, Zimmer Biomet’s stock price fell to $99.17. Shareholders have lost 12% of their capital, which is disappointing considering the S&P 500 has climbed by 24.7%. This might have ...

The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in hospitals, and a shift toward minimally invasive procedures. As of 2025, ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ("Zimmer Biomet"), a global medical technology leader, today announced it has completed the acquisition of Monogram Technologies Inc. ("Monogram"), an ...

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $98.85 1.92% Open 98.935 Day High 101.083 52 Week High 133.6 52 Week ...

Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes ...

Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better ...

Investors looked past a 22% drop in CSX’s third quarter earnings Thursday and focused on the direction the railroad’s new CEO might take it and the possibility of any strategic deals. CEO Steve Angel ...